InSightec raises $30 million

Focused-ultrasound developer InSightec of Haifa, Israel, announced it has received financing totaling $30 million, which will be used for research and development, marketing and sales, and general corporate purposes.

InsSightec plans to develop several oncology applications for its ExAblate 2000 MR-guided focused ultrasound (MRgFUS) system. The system has already received the European CE Mark for pain palliation of bone metastases, according to the company.

Related Reading

InSightec proceeds with phase I trial, September 26, 2007

InSightec nabs CE Mark, June 7, 2007

InSightec nets Canadian approval, March 12, 2007

InSightec nets FDA clearance for new software, March 5, 2007

FDA clears InSightec's ExAblate 2000 for GE 3T MRI, March 1, 2007

Copyright © 2007 AuntMinnie.com

Page 1 of 57
Next Page